STOCK TITAN

LENSAR (NASDAQ: LNSR) clarifies $9.2M Wells Fargo credit line terms

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K/A

Rhea-AI Filing Summary

LENSAR, Inc. filed an amended report to restate and clarify its disclosure about a new credit facility with Wells Fargo Bank, N.A. The company has entered into a Priority Credit Line Agreement that provides a revolving, non-purpose margin credit line secured by a first-priority lien on a designated brokerage account.

Based on the collateral value in this account, LENSAR may borrow up to $9.2 million. Borrowings accrue interest, at the company’s election, at either a fixed rate based on the Treasury Yield plus a margin over a chosen term, or a variable rate based on SOFR plus a margin. The agreement includes customary events of default tied to missed payments, collateral shortfalls, insolvency proceedings, and related security agreements.

Positive

  • None.

Negative

  • None.

Insights

LENSAR adds a secured $9.2M margin credit line with flexible rates.

The Priority Credit Line Agreement with Wells Fargo gives LENSAR access to a revolving, non-purpose margin facility of up to $9.2 million, determined by the collateral value in a pledged brokerage account. This is secured by a first-priority lien on that account.

Interest can be fixed off the Treasury Yield or variable off SOFR, each with an added margin, which lets the company choose between rate certainty and floating exposure. The listed default triggers—missed payments, inadequate collateral, insolvency, and related security defaults—are described as customary.

The filing amends and restates a prior disclosure to clarify these terms, suggesting an emphasis on precise communication around borrowing capacity and collateral mechanics. Actual balance-sheet impact will depend on how much of the line LENSAR ultimately draws.

true 0001320350 0001320350 2026-03-12 2026-03-12
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K/A

(Amendment No. 1)

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 12, 2026

 

 

LENSAR, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-39473   32-0125724

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

2800 Discovery Drive  
Orlando, Florida   32826
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: 888 536-7271

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common stock, par value $0.01 per share   LNSR   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


EXPLANATORY NOTE

This Current Report on Form 8-K/A amends and restates in its entirety Item 8.01 of the Current Report on Form 8-K filed by the Company (as defined below) on March 12, 2026 (the “Original Form 8-K”) to clarify the terms of the PCL Agreement (as defined below) that the Company entered into, as previously disclosed in the Original Form 8-K.

Item 8.01 Other Events.

On March 12, 2026, LENSAR, Inc. (the “Company”) reported that it has entered into a Priority Credit Line Agreement, dated as of March 11, 2026 (the “PCL Agreement”), by and between the Company and Wells Fargo Bank, N.A (“Wells Fargo”). The PCL Agreement provides for a revolving, non-purpose margin credit facility, secured by a first-priority lien on a designated brokerage account maintained at Wells Fargo (the “Collateral Account”), of an amount based on the collateral value in the Collateral Account. Based on the collateral value in the Collateral Account, the Company is permitted to borrow up to $9.2 million under the PCL Agreement.

Borrowings under the PCL Agreement bear interest, at the Company’s election, at either (i) a fixed rate based on the Treasury Yield plus an applicable margin, over a designated term, or (ii) a variable rate based on the Secured Overnight Financing Rate (SOFR) plus an applicable margin.

The PCL Agreement contains customary events of default, including, without limitation, failure to make any payment upon demand or otherwise when due or deposit additional collateral when required under the PCL Agreement; initiation of a bankruptcy petition or other insolvency proceeding; any event of default under any security agreement executed in connection with the Collateral Account; or the insufficiency of the value of the financial assets in the Collateral Account.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      LENSAR, Inc.
Date: March 12, 2026     By:  

/s/ Nicholas T. Curtis

     

Nicholas T. Curtis

Chief Executive Officer

FAQ

What credit facility did LENSAR (LNSR) disclose in this 8-K/A?

LENSAR disclosed a Priority Credit Line Agreement with Wells Fargo. It is a revolving, non-purpose margin credit facility secured by a first-priority lien on a designated brokerage account, allowing borrowing based on the collateral value held in that account.

How much can LENSAR borrow under the Wells Fargo Priority Credit Line?

LENSAR may borrow up to $9.2 million under the Priority Credit Line Agreement. This maximum is tied to the collateral value in the pledged brokerage account, so borrowing capacity depends on the market value of financial assets held there.

What interest rate options apply to LENSAR’s new credit line with Wells Fargo?

Borrowings under the agreement bear interest at LENSAR’s election under two structures: a fixed rate based on the Treasury Yield plus an applicable margin, or a variable rate based on SOFR plus an applicable margin, over a designated term.

What events of default are included in LENSAR’s Priority Credit Line Agreement?

The agreement lists customary events of default, including failing to pay amounts when due, failing to post additional collateral when required, bankruptcy or other insolvency proceedings, any default under related security agreements, and insufficient value of assets in the collateral account.

Why did LENSAR file an amendment to its earlier report about the credit line?

LENSAR filed this amendment to amend and restate the earlier disclosure about the Priority Credit Line Agreement. The purpose was to clarify the terms of the agreement previously reported, without changing the underlying facility itself.

Filing Exhibits & Attachments

3 documents
Lensar Inc

NASDAQ:LNSR

View LNSR Stock Overview

LNSR Rankings

LNSR Latest News

LNSR Latest SEC Filings

LNSR Stock Data

72.98M
9.64M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ORLANDO